Literature DB >> 7595383

Passage of Japanese encephalitis virus in HeLa cells results in attenuation of virulence in mice.

J X Cao1, H Ni, M R Wills, G A Campbell, B K Sil, K D Ryman, I Kitchen, A D Barrett.   

Abstract

Of four wild-type strains (Nakayama-original, SA14, 826309 and Beijing-1) of Japanese encephalitis (JE) virus that were passaged six times in HeLa cells (HeLa p6), two (Nakayama-original and 826309) became attenuated for mice. In the case of strain Nakayama-original, the virulence for mice was markedly reduced and attenuation was retained on passage in primary chicken embryo fibroblast, LLC-MK2 and C6/36 cells. The binding of non-HeLa-passaged Nakayama virus to mouse brain membrane receptor preparations could be differentiated from binding by Nakayama HeLa p6 virus, suggesting that the envelope (E) protein is involved in the attenuated phenotype. Both of the attenuated viruses can be distinguished from the virulent non-HeLa-passaged parental viruses by examination with E protein reactive vaccine and wild-type-specific monoclonal antibodies (MAbs). The vaccine-specific MAb V23, which is only reactive with the SA14 series of live vaccine viruses, recognized the HeLa cell-attenuated Nakayama-original and 826309 viruses, whereas two wild-type-specific MAbs (MAbs K13 and K39) lost reactivity. Comparison of the nucleotide sequences of the structural protein genes of the 826309 and Nakayama-original virulent parent and attenuated HeLa p6 viruses revealed that the viruses differed by 37 and 46 nucleotides coding for eight and nine amino acid mutations, respectively. However, other than one amino acid in the E protein, the membrane and E protein amino acid sequences of the two attenuated HeLa p6 viruses were identical.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595383     DOI: 10.1099/0022-1317-76-11-2757

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Effects of passage history and sampling bias on phylogenetic reconstruction of human influenza A evolution.

Authors:  R M Bush; C B Smith; N J Cox; W M Fitch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

2.  Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3.

Authors:  S Butrapet; C Y Huang; D J Pierro; N Bhamarapravati; D J Gubler; R M Kinney
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 3.  Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.

Authors:  Nagendra R Hegde; Milind M Gore
Journal:  Hum Vaccin Immunother       Date:  2017-02-22       Impact factor: 3.452

4.  JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease.

Authors:  Thomas J Chambers; Deborah A Droll; Xiaoshan Jiang; William S M Wold; Janice A Nickells
Journal:  Virology       Date:  2007-05-22       Impact factor: 3.616

5.  The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling.

Authors:  Maudry Laurent-Rolle; Elena F Boer; Kirk J Lubick; James B Wolfinbarger; Aaron B Carmody; Barry Rockx; Wenjun Liu; Joseph Ashour; W Lesley Shupert; Michael R Holbrook; Alan D Barrett; Peter W Mason; Marshall E Bloom; Adolfo García-Sastre; Alexander A Khromykh; Sonja M Best
Journal:  J Virol       Date:  2010-01-27       Impact factor: 5.103

6.  Exploring variation in the d(N)/d(S) ratio among sites and lineages using mutational mappings: applications to the influenza virus.

Authors:  Weiwei Zhai; Montgomery Slatkin; Rasmus Nielsen
Journal:  J Mol Evol       Date:  2007-09-11       Impact factor: 2.395

7.  Attenuation of Zika Virus by Passage in Human HeLa Cells.

Authors:  Li Li; Natalie D Collins; Steven G Widen; Emily H Davis; Jaclyn A Kaiser; Mellodee M White; M Banks Greenberg; Alan D T Barrett; Nigel Bourne; Vanessa V Sarathy
Journal:  Vaccines (Basel)       Date:  2019-08-20

8.  Impact of yellow fever virus envelope protein on wild-type and vaccine epitopes and tissue tropism.

Authors:  Emily H Davis; Binbin Wang; Mellodee White; Yan-Jang S Huang; Vanessa V Sarathy; Tian Wang; Nigel Bourne; Stephen Higgs; Alan D T Barrett
Journal:  NPJ Vaccines       Date:  2022-03-23       Impact factor: 9.399

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.